Literature DB >> 27050022

Arthroscopic Talar Dome Access Using a Standard Versus Wire-Based Traction Method for Ankle Joint Distraction.

Alexej Barg1, Charles L Saltzman2, Timothy C Beals3, Kent N Bachus4, Brad D Blankenhorn5, Florian Nickisch6.   

Abstract

PURPOSE: To evaluate the accessibility of the talar dome through anterior and posterior portals for ankle arthroscopy with the standard noninvasive distraction versus wire-based longitudinal distraction using a tensioned wire placed transversely through the calcaneal tuberosity.
METHODS: Seven matched pairs of thigh-to-foot specimens underwent ankle arthroscopy with 1 of 2 methods of distraction: a standard noninvasive strapping technique or a calcaneal tuberosity wire-based technique. The order of the arthroscopic approach and use of a distraction method was randomly determined. The areas accessed from both 2-portal anterior and 2-portal posterior approaches were determined by using a molded translucent grid.
RESULTS: The mean talar surface accessible by anterior ankle arthroscopy was comparable with noninvasive versus calcaneal wire distraction with 57.8% ± 17.2% (range, 32.9% to 75.7%) versus 61.5% ± 15.2% (range, 38.5% to 79.1%) of the talar dome, respectively (P = .590). The use of calcaneal wire distraction significantly improved posterior talar dome accessibility compared with noninvasive distraction, with 56.4% ± 20.0% (range, 14.4% to 78.0%) versus 39.8% ± 14.9% (range, 20.0% to 57.6%) of the talar dome, respectively (P = .031).
CONCLUSIONS: Under the conditions studied, our cadaveric model showed equivalent talar dome access with 2-portal anterior arthroscopy of calcaneal wire-based distraction versus noninvasive strap distraction, but improved access for 2-portal posterior arthroscopy with calcaneal wire-based distraction versus noninvasive strap distraction. CLINICAL RELEVANCE: The posterior 40% of the talar dome is difficult to access via anterior ankle arthroscopy. Posterior calcaneal tuberosity wire-based longitudinal distraction improved arthroscopic access to the centro-posterior talar dome with a posterior arthroscopic approach. Published by Elsevier Inc.

Mesh:

Year:  2016        PMID: 27050022     DOI: 10.1016/j.arthro.2016.01.031

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  6 in total

1.  Medial oblique malleolar osteotomy for approach of medial osteochondral lesion of the talus.

Authors:  Michel Meisterhans; Victor Valderrabano; Martin Wiewiorski
Journal:  Arch Orthop Trauma Surg       Date:  2022-09-05       Impact factor: 2.928

2.  Maximum Plantarflexion Lateral Ankle Radiograph for Preoperative Planning for the Arthroscopic Treatment of Osteochondral Lesions of the Talus.

Authors:  Justin Brohard; Kenneth M Chin
Journal:  Foot Ankle Orthop       Date:  2022-06-07

3.  Accessibility to Talar Dome in Neutral Position, Dorsiflexion, or Noninvasive Distraction in Posterior Ankle Arthroscopy.

Authors:  Lena Hirtler; Katarina Schellander; Reinhard Schuh
Journal:  Foot Ankle Int       Date:  2019-05-12       Impact factor: 2.827

4.  Incidence of concomitant chondral/osteochondral lesions in acute ankle fractures and their effect on clinical outcome: a systematic review and meta-analysis.

Authors:  Ali Darwich; Julia Adam; Franz-Joseph Dally; Svetlana Hetjens; Ahmed Jawhar
Journal:  Arch Orthop Trauma Surg       Date:  2020-10-31       Impact factor: 3.067

5.  A Technique for the Reduction of Complications Associated With Anterior Portal Placement During Ankle Arthroscopy Using a Peripheral Vein Illumination Device.

Authors:  Yusuke Tsuyuguchi; Tomoyuki Nakasa; Masakazu Ishikawa; Yasunari Ikuta; Mikiya Sawa; Masahiro Yoshikawa; Nobuo Adachi
Journal:  Arthrosc Tech       Date:  2018-01-17

6.  The Distribution Pattern of the Neurovascular Structures for Anterior Ankle Arthroscopy to Minimize Structural Injury: Anatomical Study.

Authors:  Anna Jeon; Chang Min Seo; Je-Hun Lee; Seung-Ho Han
Journal:  Biomed Res Int       Date:  2018-05-15       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.